De Rubertis Francesco

CIK 00016015213 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001601521

Recent Transactions

32 trades

Other
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2022-03-21+45,054→ 281,162 total
Other
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2022-03-21+1,794,211→ 11,197,303 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-12-02$12.82/sh+796→ 93,526 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-12-02$12.82/sh+33,530→ 3,936,970 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-12-01$12.62/sh+1,399→ 92,730 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-12-01$12.62/sh+58,905→ 3,903,440 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-30$11.62/sh+855→ 91,331 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-30$11.62/sh+35,992→ 3,844,535 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-29$11.70/sh+55,391→ 3,808,543 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-29$11.70/sh+1,315→ 90,476 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-26$11.34/sh+274→ 89,161 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-11-26$11.34/sh+11,543→ 3,753,152 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-06-02$20.00/sh+586,077→ 3,741,609 total
Conversion
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-06-02+1,886,990→ 3,155,532 total
Conversion
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-06-02+44,828→ 74,964 total
Purchase
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2021-06-02$20.00/sh+13,923→ 88,887 total
Conversion
Centessa Pharmaceuticals plc$CNTA
Series A Preferred Shares
2021-06-02−1,886,990→ 0 total
Conversion
Centessa Pharmaceuticals plc$CNTA
Series A Preferred Shares
2021-06-02−44,828→ 0 total
Award
Centessa Pharmaceuticals plc$CNTA
Series A Preferred Shares
2021-01-29$11.00/sh+1,886,990→ 1,886,990 total
Award
Centessa Pharmaceuticals plc$CNTA
Series A Preferred Shares
2021-01-29$11.00/sh+44,828→ 44,828 total
Exercise of In-Money
Minerva Neurosciences, Inc.$NERV
Warrant Shares
2016-12-12−202,634→ 0 total
Exercise of In-Money
Minerva Neurosciences, Inc.$NERV
Common Stock
2016-12-12$5.77/sh+202,634→ 4,690,906 total
Sale
Minerva Neurosciences, Inc.$NERV
Common Stock
2016-08-10$10.00/sh−1,000,000→ 4,488,272 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2015-03-18$4.81/sh+202,634→ 5,488,272 total
Purchase
Minerva Neurosciences, Inc.$NERV
Warrant Shares
2015-03-18$0.13/sh+202,634→ 202,634 total
Conversion
Minerva Neurosciences, Inc.$NERV
Convertible Promissory Note
2014-07-07$6.00/sh−61,922→ 0 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+1,287,500→ 4,952,305 total
Conversion
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+114,077→ 3,602,883 total
Conversion
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+61,922→ 3,664,805 total
Purchase
Minerva Neurosciences, Inc.$NERV
Common Stock
2014-07-07$6.00/sh+333,333→ 5,285,638 total
Conversion
Minerva Neurosciences, Inc.$NERV
Convertible Promissory Note
2014-07-07$6.00/sh−114,077→ 0 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2014-03-20+35,000→ 35,000 total

Companies

Recent Filings

Address

C/O INDEX VENTURES 5TH FLOOR, 3 BURLINGTON GARDENS

LONDON, X0, W1S 3EP

View on SEC.gov